Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding a defense contractor’s disclosure can feel like parsing mission traffic. CACI’s filings are packed with contract backlog tables, classified program risks, and cost-plus accounting notes that stretch well past 300 pages. If you have ever searched for “CACI SEC filings explained simply” or wondered how contract wins affect revenue, you know the challenge.
Stock Titan solves that problem. Our AI reads every new document the second it hits EDGAR, turning dense language into clear takeaways. Whether you need a “CACI quarterly earnings report 10-Q filing” preview or a red-flag summary of the latest 8-K material event, the platform highlights what moves the stock in minutes—no jargon required. Real-time alerts ensure “CACI Form 4 insider transactions real-time” land in your inbox before the market reacts.
Key resources we track and simplify for CACI International Inc:
- 10-K annual report insights—search “CACI annual report 10-K simplified” to see backlog trends, margin drivers, and cybersecurity spending on one screen.
- 10-Q updates—our AI links segment revenue shifts directly to Pentagon funding cycles for fast “CACI earnings report filing analysis.”
- 8-K event briefs—“CACI 8-K material events explained” clarifies contract awards, acquisitions, and leadership changes the day they’re disclosed.
- Form 4 activity—track “CACI insider trading Form 4 transactions” and “CACI executive stock transactions Form 4” to spot buying before contract announcements.
- DEF 14A proxy—answer questions like “CACI proxy statement executive compensation” without digging through PDF footnotes.
The result? Investors monitoring national-security spending, credit analysts watching cash flow timing, and researchers “understanding CACI SEC documents with AI” all gain the same edge: concise intelligence, comprehensive coverage, and the confidence that nothing slips past their radar.
CACI International (CACI) director Scott Morrison reported the vesting and settlement of restricted stock units into common stock. On 10/12/2025, a transaction coded M converted RSUs into 83 shares of CACI common stock. Following the transaction, Morrison beneficially owns 331 shares directly.
The activity reflects the final tranche of a previously disclosed 331 RSU grant made on October 17, 2024, which vested in scheduled installments across 2025, concluding with 83 shares on October 12, 2025.
CACI International (CACI) reported an insider equity change by Director William L. Jews. On October 12, 2025, 83 shares of CACI common stock were acquired through the conversion of vested RSUs (Code M), increasing his direct holdings to 6,384 shares.
The transaction reflects the final tranche from a 331 RSU grant awarded on October 17, 2024, which vested in installments: 82 shares on January 15, 2025; 83 shares on April 15, 2025; 83 shares on July 14, 2025; and 83 shares on October 12, 2025.
CACI International Inc. (CACI): Director Charles L. Szews reported the settlement of 83 shares of CACI common stock on 10/12/2025 via the conversion (Code M) of restricted stock units. Following this transaction, he beneficially owns 331 shares, held directly.
The 83-share vesting represents the final tranche of a 331 RSU grant awarded on 10/17/2024, which vested as 82 shares on 01/15/2025, 83 on 04/15/2025, 83 on 07/14/2025, and 83 on 10/12/2025.
CACI International (CACI): Director Lisa Disbrow reported the vesting and settlement of 83 restricted stock units into CACI common stock on 10/12/2025 (transaction code M). Following this transaction, she beneficially owns 1,934 shares, held directly.
The RSUs were part of a 331‑unit grant made on October 17, 2024, vesting in tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International (CACI): Director Susan M. Gordon reported the settlement of restricted stock units into common shares. On 10/12/2025, 83 RSUs vested and converted into 83 shares of CACI common stock (transaction code M), consistent with a previously disclosed grant.
The RSUs were part of a 331-unit award granted on October 17, 2024, vesting in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025. Following this vesting, Ms. Gordon directly owns 2,737 CACI shares.
This filing reflects routine equity compensation vesting for a director and does not indicate an open-market purchase or sale.
Jeffrey D. MacLauchlan, Chief Financial Officer of CACI International Inc. (CACI), reported multiple equity awards and vesting-related transactions dated
John S. Mengucci, President & CEO and director of CACI International, Inc. (CACI), reported multiple stock-based transactions on 10/01/2025 on Form 4. The filing shows a mix of acquisitions and dispositions of common stock and the vesting/granting of restricted stock units (RSUs) and performance RSUs (PRSUs). Following the transactions, Mr. Mengucci beneficially owned between 103,884 and 128,827 shares across the reported lines depending on each transaction line's cumulative totals. The report records vested and newly granted awards: 12,618 PRSUs and 12,617 RSUs granted on 10/01/2025, plus earlier grants from 2022–2024 with specified vesting schedules. Several disposition entries list a price of $515.16 per share. The filing is a routine insider report documenting compensation-related equity grants and related share movements.
DeEtte Gray, President, US Operations of CACI, reported transactions dated 10/01/2025 on a Form 4. The filing shows multiple restricted stock unit and performance restricted stock unit grants and vesting events: prior grants from 10/01/2022, 10/01/2023, and 10/01/2024 are described, and new grants on 10/01/2025 include 2,233 performance RSUs and 2,232 restricted stock units. The Form 4 also records a series of non-derivative transactions on the same date including dispositions executed at a reported price of $515.16. The tables list changing beneficial ownership totals after each reported event for CACI common stock. The signature date on the form is 10/03/2025.
Tracy Weir, Chief Executive Officer, UK of CACI International Inc. (CACI), reported multiple transactions dated 10/01/2025. The Form 4 shows grants of 291 restricted stock units and 292 performance restricted stock units (total 583 units) granted on that date; the PRSUs vest on the third anniversary subject to a three‑year performance measure and the RSUs vest one‑third per year over three years. The filing also records multiple dispositions totaling 413 shares sold at $515.16 per share, and changes in beneficial ownership levels reported after each transaction. The report is a routine insider filing documenting equity awards and share sales by an executive.
J. William Koegel Jr., EVP & General Counsel of CACI (CACI) reported multiple transactions dated 10/01/2025. The filing shows the vesting/acquisition of 4,442 common shares through restricted stock units and performance restricted stock units and the grant of 971 additional restricted stock units plus 971 performance restricted stock units. Concurrently, the report discloses dispositions of 2,101 common shares at $515.16 per share. After these transactions, Mr. Koegel beneficially owned 27,931 shares of CACI common stock, held directly.
FAQ
What is the current stock price of Caci Intl (CACI)?
What is the market cap of Caci Intl (CACI)?
